REGENERON PHARMACEUTICALS, INC. Insider Trading for November 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REGENERON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in REGENERON PHARMACEUTICALS, INC. for November 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 26 2014 | REGN | REGENERON PHARMACE ... | POON CHRISTINE A | Director | Buy | P | 410.00 | 400 | 164,000 | 655 | 255 to 655 (+156.86 %) |
| Nov 25 2014 | REGN | REGENERON PHARMACE ... | GILMAN ALFRED G | Director | Option Exercise | M | 57.11 | 10,000 | 571,100 | 5,000 | |
| Nov 25 2014 | REGN | REGENERON PHARMACE ... | GILMAN ALFRED G | Director | Option Exercise | M | 33.42 | 15,000 | 501,300 | 0 | |
| Nov 25 2014 | REGN | REGENERON PHARMACE ... | GILMAN ALFRED G | Director | Option Exercise | M | 24.41 | 15,000 | 366,150 | 0 | |
| Nov 25 2014 | REGN | REGENERON PHARMACE ... | GILMAN ALFRED G | Director | Sell | S | 411.06 | 4,140 | 1,701,788 | 0 | 4.1 K to 0 (-100.00 %) |
| Nov 25 2014 | REGN | REGENERON PHARMACE ... | GILMAN ALFRED G | Director | Sell | S | 410.05 | 7,500 | 3,075,375 | 4,140 | 11.6 K to 4.1 K (-64.43 %) |
| Nov 25 2014 | REGN | REGENERON PHARMACE ... | GILMAN ALFRED G | Director | Sell | S | 409.00 | 7,500 | 3,067,500 | 11,640 | 19.1 K to 11.6 K (-39.18 %) |
| Nov 25 2014 | REGN | REGENERON PHARMACE ... | GILMAN ALFRED G | Director | Sell | S | 407.93 | 9,933 | 4,051,969 | 19,140 | 29.1 K to 19.1 K (-34.17 %) |
| Nov 25 2014 | REGN | REGENERON PHARMACE ... | GILMAN ALFRED G | Director | Sell | S | 406.98 | 6,327 | 2,574,962 | 29,073 | 35.4 K to 29.1 K (-17.87 %) |
| Nov 25 2014 | REGN | REGENERON PHARMACE ... | GILMAN ALFRED G | Director | Sell | S | 405.65 | 4,600 | 1,865,990 | 35,400 | 40 K to 35.4 K (-11.50 %) |
| Nov 25 2014 | REGN | REGENERON PHARMACE ... | GILMAN ALFRED G | Director | Buy | M | 57.11 | 10,000 | 571,100 | 40,000 | 30 K to 40 K (+33.33 %) |
| Nov 25 2014 | REGN | REGENERON PHARMACE ... | GILMAN ALFRED G | Director | Buy | M | 33.42 | 15,000 | 501,300 | 30,000 | 15 K to 30 K (+100.00 %) |
| Nov 25 2014 | REGN | REGENERON PHARMACE ... | GILMAN ALFRED G | Director | Buy | M | 24.41 | 15,000 | 366,150 | 15,000 | 0 to 15 K |
| Nov 24 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Sell | S | 410.10 | 413 | 169,371 | 3,277 | 3.7 K to 3.3 K (-11.19 %) |
| Nov 24 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Sell | S | 409.71 | 1,787 | 732,152 | 3,690 | 5.5 K to 3.7 K (-32.63 %) |
| Nov 24 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Sell | S | 415.16 | 3,107 | 1,289,902 | 5,477 | 8.6 K to 5.5 K (-36.20 %) |
| Nov 20 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Option Exercise | M | 115.29 | 16,757 | 1,931,915 | 0 | |
| Nov 20 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Gift | G | 0.00 | 250 | 0 | 18,584 | 18.8 K to 18.6 K (-1.33 %) |
| Nov 20 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Payment of Exercise | F | 406.93 | 6,703 | 2,727,652 | 18,834 | 25.5 K to 18.8 K (-26.25 %) |
| Nov 20 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Payment of Exercise | F | 406.93 | 4,747 | 1,931,697 | 25,537 | 30.3 K to 25.5 K (-15.67 %) |
| Nov 20 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Buy | M | 115.29 | 16,757 | 1,931,915 | 30,284 | 13.5 K to 30.3 K (+123.88 %) |
| Nov 19 2014 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Option Exercise | M | 21.25 | 48,750 | 1,035,938 | 0 | |
| Nov 19 2014 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 408.62 | 1,800 | 735,516 | 20,029 | 21.8 K to 20 K (-8.25 %) |
| Nov 19 2014 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 407.85 | 2,200 | 897,270 | 21,829 | 24 K to 21.8 K (-9.16 %) |
| Nov 19 2014 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 406.89 | 3,720 | 1,513,631 | 24,029 | 27.7 K to 24 K (-13.41 %) |
| Nov 19 2014 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 405.85 | 7,278 | 2,953,776 | 27,749 | 35 K to 27.7 K (-20.78 %) |
| Nov 19 2014 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 404.75 | 3,252 | 1,316,247 | 35,027 | 38.3 K to 35 K (-8.50 %) |
| Nov 19 2014 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 403.86 | 2,150 | 868,299 | 38,279 | 40.4 K to 38.3 K (-5.32 %) |
| Nov 19 2014 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 402.71 | 1,500 | 604,065 | 40,429 | 41.9 K to 40.4 K (-3.58 %) |
| Nov 19 2014 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 401.42 | 400 | 160,568 | 41,929 | 42.3 K to 41.9 K (-0.94 %) |
| Nov 19 2014 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 400.45 | 62 | 24,828 | 42,329 | 42.4 K to 42.3 K (-0.15 %) |
| Nov 19 2014 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Payment of Exercise | F | 401.75 | 23,810 | 9,565,668 | 42,391 | 66.2 K to 42.4 K (-35.97 %) |
| Nov 19 2014 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Payment of Exercise | F | 401.75 | 2,578 | 1,035,712 | 66,201 | 68.8 K to 66.2 K (-3.75 %) |
| Nov 19 2014 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Buy | M | 21.25 | 48,750 | 1,035,938 | 68,779 | 20 K to 68.8 K (+243.40 %) |
| Nov 14 2014 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Option Exercise | M | 21.25 | 18,700 | 397,375 | 37,895 | |
| Nov 14 2014 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 399.95 | 1,501 | 600,325 | 15,441 | 16.9 K to 15.4 K (-8.86 %) |
| Nov 14 2014 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 399.21 | 7,074 | 2,824,012 | 16,942 | 24 K to 16.9 K (-29.46 %) |
| Nov 14 2014 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Payment of Exercise | F | 398.93 | 9,129 | 3,641,832 | 24,016 | 33.1 K to 24 K (-27.54 %) |
| Nov 14 2014 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Payment of Exercise | F | 398.93 | 996 | 397,334 | 33,145 | 34.1 K to 33.1 K (-2.92 %) |
| Nov 14 2014 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Buy | M | 21.25 | 18,700 | 397,375 | 34,141 | 15.4 K to 34.1 K (+121.11 %) |
| Nov 12 2014 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Option Exercise | M | 177.82 | 5,000 | 889,100 | 10,000 | |
| Nov 12 2014 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Sell | S | 398.31 | 5,000 | 1,991,550 | 4,000 | 9 K to 4 K (-55.56 %) |
| Nov 12 2014 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Buy | M | 177.82 | 5,000 | 889,100 | 9,000 | 4 K to 9 K (+125.00 %) |
| Nov 12 2014 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 401.12 | 4,860 | 1,949,443 | 42,087 | 46.9 K to 42.1 K (-10.35 %) |
| Nov 12 2014 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 400.22 | 37,464 | 14,993,842 | 46,947 | 84.4 K to 46.9 K (-44.38 %) |
| Nov 12 2014 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 400.00 | 3,493 | 1,397,200 | 84,411 | 87.9 K to 84.4 K (-3.97 %) |
| Nov 04 2014 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 400.11 | 3,453 | 1,381,580 | 87,904 | 91.4 K to 87.9 K (-3.78 %) |